Genentech rejects $43.7 billion Roche offer
This article was originally published in Scrip
Executive Summary
Genentech has rejected a takeover offer from its majority owner Roche, saying that the $43.7 billion offer "substantially undervalues the company". The US biotechnology firm said that while the unsolicited bid was too low, it would consider an improved offer.